Evidence map›Paper›PMID 33060618›Full record

ArticleScientific reports2020

Differential susceptibility of retinal ganglion cell subtypes in acute and chronic models of injury and disease.

Kirstin B VanderWall, Bin Lu, Jorge S Alfaro, Anna R Allsop, Alexa S Carr, Shaomei Wang, Jason S Meyer

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Astrocytes in the mouse brain respond bilaterally to unilateral retinal neurodegeneration.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kirstin B VanderWallDepartment of Biology, Indiana University Purdue University Indianapolis, Indianapolis, IN, 46202, USA.
Bin LuDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, CA, 90048, USA.
Jorge S AlfaroDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, CA, 90048, USA.
Anna R AllsopDepartment of Biology, Indiana University Purdue University Indianapolis, Indianapolis, IN, 46202, USA.
Alexa S CarrDepartment of Biology, Indiana University Purdue University Indianapolis, Indianapolis, IN, 46202, USA.
Shaomei WangDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Regenerative Medicine Institute, Los Angeles, CA, 90048, USA. Shaomei.Wang@cshs.org.
Jason S MeyerDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, 46202, USA. meyerjas@iu.edu.

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Derivation and Disease Modeling of Human Stem Cell-Derived Retinal Ganglion CellsR01EY024984 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI MEYER, JASON STEPHEN · 2015 to 2019
$2.1M
Targeting the diversity of retinal ganglion cells for replacement therapyR21EY031120 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI FORTUNE, BRAD, MEYER, JASON STEPHEN · 2019 to 2019
$346k
NCATS NIH HHS UL1 TR002529NEI NIH HHS R01 EY024984NEI NIH HHS R21 EY031120NIH HHS R01EY024984NIH HHS UL1TR002529
6 · The paper itself

Abstract

Retinal ganglion cells (RGCs) are a heterogeneous population of neurons, comprised of numerous subtypes that work synchronously to transmit visual information to the brain. In blinding disorders such as glaucoma, RGCs are the main cell type to degenerate and lead to loss of vision. Previous studies have identified and characterized a variety of RGC subtypes in animal models, although only a handful of studies demonstrate the differential loss of these RGC subtypes in response to disease or injury. Thus, efforts of the current study utilized both chronic (bead occlusion) and acute (optic nerve crush, ONC) rat models to characterize disease response and differential loss of RGC subtypes. Bead occlusion and ONC retinas demonstrated significant RGC loss, glial reactivity and apoptosis compared to control retinas. Importantly, bead occlusion and ONC retinas resulted in differential subtype-specific loss of RGCs, with a high susceptibility for alpha- and direction selective-RGCs and preferential survival of ipRGCs. Results of this study serve as an important foundation for future experiments focused on the mechanisms resulting in the loss of RGCs in optic neuropathies, as well as the development of targeted therapeutics for RGC subtype-specific neuroprotection.

Indexed as

Disease Models, AnimalModels, BiologicalAcute DiseaseAnimalsChronic DiseaseNeuroprotective AgentsOptic Nerve InjuriesRatsRats, Long-EvansRats, Sprague-DawleyRetinal Ganglion CellsNeuroprotective Agents

Identifiers

PMID33060618
PMCPMC7566630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.